The value and role of anti-angiogenesis in solid tumours and the mechanism to inhibit angiogenesis

 

The aim of this evaluation form is to gain your feedback, in order to maintain high educational standards and provide a reference for continuous improvement. Please indicate which rating reflects your answer.

Questions marked with are required.

1. Did this E-Learning module provide you with an update on neoangiogenesis in solid tumours and the value of its inhibition? (1-not at all; 5-yes absolutely)

2. Did this E-Learning module provide you with an update on anti-angiogenic agents, their mechanism of action, and the role they have in the management of various solid tumours? (1-not at all; 5-yes absolutely)

3. Did this E-Learning module summarise results from the clinical studies with anti-angiogenic agents in various solid tumours? (1-not at all; 5-yes absolutely)

4. Please, provide your overall rating of the quality of the education offered by this E-Learning module. (1-poor; 5-excellent)

5. How would you rate the interactivity level offered in the E-Learning material? (1-poor; 5-excellent)

6. Was the information useful and relevant to your work and practice? (1-not at all; 5-absolutely)

7. Do you feel that the information presented was well balanced and supported by adequate evidence? (1-not at all; 5-absolutely)

8. If you would like to add your personal comments or make suggestion to improve future ESMO E-Learning material, please write in the box below: